{"denoms":[{"counts":[{"groupId":"BG000","value":"157"},{"groupId":"BG001","value":"149"},{"groupId":"BG002","value":"306"}],"units":"Participants"}],"groups":[{"description":"Cisplatin: 40 mg/m2 IV (intravenously) weekly for 6 weeks\n\nIMRT 6 weeks: Intensity-modulated radiation therapy (IMRT), 30 fractions over 6 weeks, 5 fractions per week, 2 Gray per fraction to total dose of 60 Gy","id":"BG000","title":"IMRT 6 Weeks + Cisplatin"},{"description":"IMRT 5 weeks: Intensity-modulated radiation therapy (IMRT), 30 fractions over 5 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 60 Gy","id":"BG001","title":"IMRT 5 Weeks"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"42"}],"title":"≤ 49"},{"measurements":[{"groupId":"BG000","value":"56"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"116"}],"title":"50 - 59"},{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"55"},{"groupId":"BG002","value":"101"}],"title":"60 - 69"},{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"47"}],"title":"≥ 70"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"49"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"133"},{"groupId":"BG001","value":"124"},{"groupId":"BG002","value":"257"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"10"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"143"},{"groupId":"BG001","value":"130"},{"groupId":"BG002","value":"273"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"23"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"4"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"130"},{"groupId":"BG002","value":"281"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"16"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"132"},{"groupId":"BG001","value":"113"},{"groupId":"BG002","value":"245"}],"title":"0: Asymptomatic"},{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"36"},{"groupId":"BG002","value":"61"}],"title":"1: Symptomatic but completely ambulatory"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Zubrod performance status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"112"},{"groupId":"BG001","value":"101"},{"groupId":"BG002","value":"213"}],"title":"0"},{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"32"},{"groupId":"BG002","value":"58"}],"title":">0 - <5"},{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"35"}],"title":"5 - 10"}]}],"description":"Smoking history as measured in pack-years, calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked.","paramType":"COUNT_OF_PARTICIPANTS","title":"Smoking history (pack years)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"17"}],"title":"Oropharynx NOS (not otherwise specified)"},{"measurements":[{"groupId":"BG000","value":"83"},{"groupId":"BG001","value":"78"},{"groupId":"BG002","value":"161"}],"title":"Tonsillar fossa, tonsil"},{"measurements":[{"groupId":"BG000","value":"68"},{"groupId":"BG001","value":"58"},{"groupId":"BG002","value":"126"}],"title":"Base of tongue"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Pharyngeal oropharynx"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Posterior pharyngeal wall"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Primary tumor site","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"64"},{"groupId":"BG001","value":"51"},{"groupId":"BG002","value":"115"}],"title":"T1"},{"measurements":[{"groupId":"BG000","value":"67"},{"groupId":"BG001","value":"80"},{"groupId":"BG002","value":"147"}],"title":"T2"},{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"44"}],"title":"T3"}]}],"description":"Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues. T's may be further divided to provide more detail, such as T3a and T3b.","paramType":"COUNT_OF_PARTICIPANTS","title":"T stage, clinical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"13"}],"title":"N0"},{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"62"}],"title":"N1"},{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"43"}],"title":"N2a"},{"measurements":[{"groupId":"BG000","value":"99"},{"groupId":"BG001","value":"89"},{"groupId":"BG002","value":"188"}],"title":"N2b"}]}],"description":"Regional lymph nodes staging per American Joint Committee on Cancer (AJCC) 7th ed. refers to the number and/or extent of spread of lymph nodes that contain cancer. The higher the number after the N, the greater the involvement of regional lymph nodes.","paramType":"COUNT_OF_PARTICIPANTS","title":"N stage, clinical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"52"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"99"}],"title":"Unilateral"},{"measurements":[{"groupId":"BG000","value":"105"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"207"}],"title":"Bilateral"}]}],"description":"Radiation therapy plan included unilateral or bilateral radiation to the neck, as provided by the treating site at stratification.","paramType":"COUNT_OF_PARTICIPANTS","title":"Radiation Therapy (RT) planning (as stratified)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"37"}],"title":"Unilateral"},{"measurements":[{"groupId":"BG000","value":"136"},{"groupId":"BG001","value":"125"},{"groupId":"BG002","value":"261"}],"title":"Bilateral"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"8"}],"title":"Unknown"}]}],"description":"Radiation therapy plan included unilateral or bilateral radiation to the neck, as provided by central review by the study radiation oncologist.","paramType":"COUNT_OF_PARTICIPANTS","title":"RT planning (per central review)","unitOfMeasure":"Participants"}],"populationDescription":"Randomized and eligible patients"}